Vanderbilt HIV Clinical Research Unit
Vanderbilt HIV Clinical Trials Unit (CTU)
This program runs HIV treatment, vaccine, and prevention trials for people living with or at risk for HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11237980 on NIH RePORTER |
What this research studies
If I join this unit, I would be taking part in HIV treatment, vaccine, or prevention studies run by teams at Vanderbilt and Washington University. The unit works with national networks (ACTG, HVTN, HPTN) to enroll participants from regions with high HIV rates. Participants typically come for clinic visits, give medical history and blood samples, and follow study procedures over time. The goal is to test new medications, vaccines, and prevention approaches and share results to improve care.
Who could benefit from this research
Good fit: Ideal candidates are adults and adolescents living with HIV or people at high risk of acquiring HIV who can attend clinic visits in Nashville or St. Louis.
Not a fit: People who are not living with HIV and have low risk of exposure, or those unable to travel to the study sites, may not gain direct benefit from these trials.
Why it matters
Potential benefit: If successful, this work could lead to better HIV treatments, vaccines, and prevention options that improve health and reduce new infections.
How similar studies have performed: Prior trials run by the ACTG, HVTN, and HPTN have produced major advances in HIV treatment and prevention, though vaccine development continues to be challenging.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Haas, David W — Vanderbilt University Medical Center
- Study coordinator: Haas, David W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.